A caution by the Food and Drug Administration about the potentially life-threatening effects of Johnson & Johnson's Ortho Evra contraceptive patch has fanned the flames of what could become nationwide litigation. Suits claim that patch users have suffered strokes, heart attacks and even death as a result of blood clotting caused by heightened estrogen levels. Web sites are publicizing the FDA directive and the litigation options available -- and federal suits are popping up around the country.
Font Size: 
FDA Notice About Contraceptive Patch Sparks Suits
New Jersey Law Journal
December 5, 2005
This article requires premium access
This article requires premium access to Law.com. Please sign in or subscribe to read the full text.
